AFFYMAX INC Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2014-09-24: Form 8-K; Period of report 2014-09-24; Description 8.01 Other Events; Details 8.01.
- 2014-07-18: Form 8-K; Period of report 2014-07-11; Description 8.01 Other Events; Details 8.01.
- 2014-06-24: Form 8-K; Period of report 2014-06-24; Description 8.01 Other Events; Details 8.01.
- 2014-06-13: Form 8-K; Period of report 2014-06-13; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2014-09-24 | 8-K | 2014-09-24 | 8.01 Other Events | 8.01 On September 23, 2014, Affymax, Inc. (“Affymax”) commenced a special meeting of stockholders to approve a plan of liquidation and dissolution, and a related proposal, as described in the proxy statement for the meeting (the “Special Meeting”). | doc110550042_v1xaffymax-8x.htm |
| 2014-07-18 | 8-K | 2014-07-11 | 8.01 Other Events | 8.01 On July 11, 2014, the California Superior Court for the County of Santa Clara granted preliminary approval of the settlement of the consolidated derivative action against certain current and former directors and officers of Affymax, Inc. (“Affymax” or the “Company”), and against Affymax as a nominal defendant, and the Court set a further hearing, currently scheduled for September 19, 2014, to consider final approval of the settlement. | a8-kpreliminaryapprovalofd.htm |
| 2014-06-24 | 8-K | 2014-06-24 | 8.01 Other Events | 8.01 On June 24, 2014, Affymax, Inc. (“Affymax” or the “Company”) issued a press release announcing that its Board of Directors (the “Board”) determined that it is in the best interests of Affymax’s stockholders to liquidate Affymax’s assets and to dissolve Affymax. | a8-k6x24x14.htm |
| 2014-06-13 | 8-K | 2014-06-13 | 2.02 Results of Operations and Financial Condition | 2.02 On June 10, 2014, Affymax, Inc. (“Affymax”) received from Takeda Pharmaceutical Company Limited (“Takeda,” and together with Affymax, the “Parties” ) a written notice of termination (the “Notice”) of the Collaboration and License Agreement between the Parties, dated June 27, 2006, as amended (the “Agreement”). | doc107716633_v2xaffymax-fo.htm |
| 2014-05-14 | 8-K | 2014-05-08 | 8.01 Other Events | 8.01 On May 8, 2014, Affymax, Inc. (the “Company”) agreed to the terms of a settlement of the securities class action suit, Bartelt v. | a8-klitigationsettlement.htm |